Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor killing, selectivity, and potential for pioneering new cancer therapeutics.
Key findingReview of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor kil
What the researchers found
Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor killing, selectivity, and potential for pioneering new cancer therapeutics.
Why it matters
Relevant to expanding peptide-based therapeutic applications.
The numbers in context
Review covers multiple snake species and their venom-derived peptides across various cancer types and mechanisms.
How the study worked
Methodology detailed in publication.
Who was studied
Review covering preclinical cancer research with snake venom-derived peptides
What this study cannot tell us
Limitations in publication.
How to read the evidence
Based on study design in publication.
When this study was published
Published in 2025.
The bigger picture
Contributes to the growing evidence for peptide therapeutics.
Questions still open
- Long-term implications?
- Comparison to existing evidence?
- Next research steps?
Common questions
What does this mean?
How reliable?
Read the original research
Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies.
Biochimica et biophysica acta. Reviews on cancer, 1880(6), 189479
Citation
Almeida, José R; Pinos-Tamayo, Edgar A; Mendes, Bruno; Robles-Loaiza, Alberto A; Syahputra, Rony Abdi; Oliveira, Ana Gabriela Silva; Ribeiro, Rosy Iara Maciel de A. (2025). Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies.. Biochimica et biophysica acta. Reviews on cancer, 1880(6), 189479. https://doi.org/10.1016/j.bbcan.2025.189479